Enjoy complimentary customisation on priority with our Enterprise License!
The nutrigenomics market share is expected to increase by USD 690.14 million from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 12.4%.
The market research report provides valuable insights into the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by application (obesity, cardiovascular diseases, and cancer research) and geography (North America, Europe, Asia, and Rest of World (ROW)).
The nutrigenomics market report offers information on several market vendors, including BASF SE, Cell Logic Pty Ltd, Cura Integrative Medicine, DNA Life, Fagron NV, geneOmbio Technologies Pvt Ltd., Genetic Healing, Genova Diagnostics Inc., Greenarray, Holistic Health International LLC, Koninklijke DSM NV, Metagenics Inc., My DNA Health Ltd., NutriFit Canada, Nutrigenomix Inc., ORIG3N Inc., Preventine Life Care, The Gene Box, and Xcode Life Sciences Pvt. Ltd among others.
Cell Logic Pty Ltd - Cell Logic Pty Ltd is a privately held company headquartered in Australia. It is a regional company, with limited information regarding its financials and limited information regarding its employee strength is available. Its revenue from the global market contributes to its overall revenues and other offerings, but it is not a key revenue stream for the company. The company offers nutrigenomics products such as EnduraCell Plus.
Get the Nutrigenomics Market Size Forecast by Download Report Sample
Technavio categorizes the global nutrigenomics market as a part of the global life science tools and services market. Our research report extensively covers external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the market during the forecast period.
Based on our research output, there has been a neutral impact on the market growth during and post-COVID-19 era. The increasing cost of medical treatment is notably driving the market growth, although factors such as high cost and unavailability of user-friendly tools for easy interpretation of data may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Nutrigenomics Market Driver
Key Nutrigenomics Market Trend
Rising demand for training in and awareness of nutrigenomics technologies is one of the key market trends propelling market growth. The market is witnessing increased demands for training and creating more awareness about the technologies available for nutrigenomics and the following are some of the institutions offering training to the students:
The aforementioned instances may propel the market growth during the forecast period.
Key Nutrigenomics Market Challenge
This market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Our In-house experts produce extensive information on the value chain and parent market of the nutrigenomics market, which vendors can leverage to gain a competitive advantage during the forecast period. The Value Chain information provides an end-to-end understanding of product insight and profit and also optimization and evaluation of business strategies. The players across the value chain include selective data and analysis from entire research findings as per the scope of the report.
Get a glance at the market share of various regions Request PDF Sample now!
41% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for the nutrigenomics market in North America. Market growth in this region will be slower than the growth of the market in Asia.
The high number of people with cancer, chronic diseases, and obesity will facilitate the market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The COVID-19 pandemic in 2020 had a negative impact on the market in North America, which resulted in the temporary closure of various industries, including those manufacturing nutrigenomics kits. However, the market is expected to witness positive growth post-COVID-19 during the forecast period, owing to various factors such as the increasing adoption of technologically advanced products by healthcare providers, a rise in healthcare expenditures, and growth in the number of advanced healthcare facilities in several countries such as the US, Canada, and various countries across the region.
To gain insights on the market contribution of various segments Request PDF Sample
The market share growth by the obesity segment will be significant during the forecast period. Obesity causes many diseases, such as osteoarthritis, gout breathing problems, and others. In nutrigenomics, nutrients are considered as indicators that inform a specific cell in the body about the diet. The nutrients are detected by a sensor system in the cell, which works like sensory ecology wherein the cell obtains information through the signal, namely, the nutrient, about its environment. Differences in the regulation as a result of differences in genes between individuals are also being studied. By acquiring knowledge in this area, nutrigenomics aids in increasing the understanding of how varying nutrition influences metabolic pathways and homeostatic control, which then can be used to prevent the development of chronic diet-related diseases such as obesity. This is driving the segment growth.
This report provides an accurate prediction of the contribution of all the segments to the growth of the market size and actionable market insights on the post-COVID-19 impact on each segment.
Nutrigenomics Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 12.4% |
Market growth 2022-2026 |
USD 690.14 million |
Market structure |
Fragmented |
YoY growth (%) |
11.8 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 41% |
Key consumer countries |
US, Canada, Germany, UK, and France |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
BASF SE, Cell Logic Pty Ltd, Cura Integrative Medicine, DNA Life, Fagron NV, geneOmbio Technologies Pvt Ltd., Genetic Healing, Genova Diagnostics Inc., Greenarray, Holistic Health International LLC, Koninklijke DSM NV, Metagenics Inc., My DNA Health Ltd., NutriFit Canada, Nutrigenomix Inc., ORIG3N Inc., Preventine Life Care, The Gene Box, and Xcode Life Sciences Pvt. Ltd |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.